Search Within

Martin Stuart Tallman

Formats
  1. Journal Article (320)
  2. Meeting Abstract (279)
  3. Review (19)
  4. Editorial (9)
  5. Book Section (8)
  6. Research Letter (8)
  7. Guidelines (6)
  8. Correspondence (1)
Groups
  1. Adult Leukemia (650)
  2. Center for Hematologic Malignancies (650)
  3. Department of Medicine (650)
  4. Hematologic Malignancies, Division of (650)
  5. GSK Faculty (164)
  6. Executive Committee, Center for Hematologic Malignancies (156)

More Groups

People
  1. Ross Levine (131)
  2. Eytan Stein (114)
  3. Jae Park (79)
  4. Omar Abdel-Wahab (68)
  5. Sean Devlin (65)
  6. Dan Douer (50)

More People

Years
  1. 2025 (3)
  2. 2024 (8)
  3. 2023 (10)
  4. 2022 (26)
  5. 2021 (45)
  6. 2020 (51)

More Years

Publications
  1. Blood (273)
  2. Journal of Clinical Oncology (41)
  3. Leukemia Research (27)
  4. Blood Advances (26)
  5. Leukemia and Lymphoma (26)
  6. Haematologica (24)

More Publications

Publishers
  1. American Society of Hematology (299)
  2. Elsevier Inc. (43)
  3. American Society of Clinical Oncology (41)
  4. Nature Publishing Group (38)
  5. Taylor & Francis Group (28)
  6. Elsevier Ltd (27)

More Publishers

Results (650)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The aberrantly expressed long noncoding RNA, TRERNA1, predicts for aggressive disease in chronic lymphocytic leukemia
    Meeting Abstract

    Miller, C. R.; Ruppert, A. S.; Coombes, K.; Lehman, A. M.; Blachly, J. S.; Lucas, D. M.; Grever, M. R.; Tallman, M. S.; Flinn, I. W.; Rassenti, L. Z.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A clinical measure of DNA methylation predicts outcome in de novo AML
    Meeting Abstract

    Luskin, M. R.; Gimotty, P.; Smith, C.; Loren, A.; Figueroa, M.; Harrison, J.; Sun, Z. X.; Tallman, M. S.; Paietta, E.; Litzow, M. R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • High response rate of moxetumomab pasudotox in relapsed/refractory hairy cell leukemia includes eradication of minimal residual disease: Potential importance for outcome
    Meeting Abstract

    Kreitman, R. J.; Arons, E.; Tallman, M. S.; Tadeusz, R.; Coutre, S.; Wilson, W. H.; Stetler-Stevenson, M.; Yuan, C. M.; Lanasa, M.; FitzGerald, D. J. P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • AUY922, a Heat Shock Protein 90 (Hsp90) inhibitor, demonstrates activity in patients with myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Hobbs, G.; Litvin, R.; Ahn, J.; McKenney, A. S.; Mauro, M. J.; Tallman, M. S.; Berman, E.; Heaney, M. L.; Levine, R. L.; Rampal, R. K.
    Blood (2015)

    Fulltext@MSK | Save
  • Cytogenetics in hairy cell leukemia at diagnosis and relapse: The rate of therapy-related myeloid malignancies is low
    Meeting Abstract

    Getta, B.; Abdel-Wahab, O.; Park, J. H.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Herpes zoster is more frequent in patients receiving higher cumulative doses of arsenic trioxide and is mitigated by prophylactic acyclovir
    Meeting Abstract

    Glass, J. L.; Kishtagari, A.; Douer, D.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Next-generation sequencing of matched normal blood identifies clonal hematopoiesis in a significant subset of solid tumor patients without hematologic malignancies
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Middha, S.; Cheng, D.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Response to hypomethylating agent therapy in acute myeloid leukemia based upon mutations in the DNA methylation pathway
    Meeting Abstract

    Coombs, C. C.; Devlin, S.; Dixit, S.; Mohanty, A.; Knapp, K. M.; Arcila, M.; Klimek, V. M.; Tallman, M. S.; Levine, R. L.; Rampal, R. K.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The peptidic CXCR4 antagonist, BL-8040, significantly reduces bone marrow immature leukemia progenitors by inducing differentiation, apoptosis and mobilization: Results of the dose escalation clinical trial in acute myeloid leukemia
    Meeting Abstract

    Borthakur, G.; Ofran, Y.; Nagler, A.; Rowe, J. M.; Foran, J. M.; Uy, G. L.; DiPersio, J. F.; Altman, J. K.; Frankfurt, O.; Tallman, M. S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Patient characteristics and early death predictors in acute promyelocytic leukaemia patients; Experience from United Arab Emirates (UAE)
    Meeting Abstract

    Alzaabi, M. R.; Hassan, I. B.; Tallman, M. S.; Alam, A.; Al Qawasmeh, K.; Kristensen, J.
    Blood (2015)

    Fulltext@MSK | Save